NKG2A inhibits TH2 cell effector function <it>in vitro</it>
<p>Abstract</p> <p>Background</p> <p>We previously reported that NKG2A, a key inhibitory ligand for HLA-E, is expressed on activated TH2 but not TH1 cells. Here we measured cytokine expression in human <it>ex vivo </it>TH2 cells upon activation with anti-CD3...
Main Authors: | Mojgani Bahar, Freishtat Robert J, Nazemzadeh Maryam, Nagaraju Kanneboyina, Hoffman Eric P |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2007-10-01
|
Series: | BMC Pulmonary Medicine |
Online Access: | http://www.biomedcentral.com/1471-2466/7/14 |
Similar Items
-
Expansion of circulating NKG2D+ effector memory T-cells and expression of NKG2D-ligand MIC in granulomaous lesions in Wegener's granulomatosis.
by: Capraru, D, et al.
Published: (2008) -
Monalizumab: inhibiting the novel immune checkpoint NKG2A
by: Thorbald van Hall, et al.
Published: (2019-10-01) -
NKG2A silencing in effector cells to improve effectivity of cell based therapeutics
by: Seltsam A, et al.
Published: (2009-02-01) -
NKG2D signaling certifies effector CD8 T cells for memory formation
by: Cynthia Perez, et al.
Published: (2019-02-01) -
NKG2A expression identifies a subset of human Vδ2 T cells exerting the highest antitumor effector functions
by: Valentina Cazzetta, et al.
Published: (2021-10-01)